BIOMAT Database Logo BIOMAT Database Logo

[A case of recurrent esophageal cancer successfully treated with concurrent radiochemotherapy with low-dose docetaxel plus 5-FU]. 2007

Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
Surgery II, Dept. of Oncological Science, Faculty of Medicine, Oita University.

A 70-year-old woman, who had undergone esophagectomy for cervical esophageal squamous cell carcinoma (pT3pN2M0, Stage III) 9 months earlier, was diagnosed as mediastinal lymph node recurrence by CT and endoscope. Patients underwent radiochemotherapy with 5 cycles of docetaxel 10 mg/m(2) on day 1 and 5-FU 250 mg/m(2) on day 1 to day 5, together with concurrent radiation (50 Gy/25 Fr) for mediastinum. After this treatment, a complete response (CR) was achieved, and there was no recurrence 9 months after the treatment. No severe adverse effects were observed. Concurrent radiochemotherapy with docetaxel and 5-FU is considered effective without serious side effects for postoperative recurrence in esophageal cancer.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008482 Mediastinum A membrane in the midline of the THORAX of mammals. It separates the lungs between the STERNUM in front and the VERTEBRAL COLUMN behind. It also surrounds the HEART, TRACHEA, ESOPHAGUS, THYMUS, and LYMPH NODES.
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[Two cases of recurrent lung cancer successfully treated with concurrent radiochemotherapy with vinorelbine plus cisplatin].
October 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[A case of advanced esophageal cancer successfully treated by concurrent use of radiotherapy and low-dose CDDP and continuous infusion of 5-FU].
March 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[A Case of Advanced Esophageal Cancer Successfully Treated with Neoadjuvant Chemotherapy Containing 5-FU, Docetaxel. and Nedaplatin Combination Therapy].
December 2018, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[An elderly case of advanced cervical esophageal cancer successfully treated with UFT after chemoradiotherapy with docetaxel/5-FU/CDDP].
August 2007, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[A case of recurrent sigmoid colon cancer successfully treated with 5-FU and UFT].
March 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[A case of recurrent esophageal cancer with lung metastases successfully treated with docetaxel-combination chemotherapy].
May 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[A case of recurrent breast cancer successfully treated with docetaxel].
March 2001, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[A case of recurrent breast cancer successfully treated with docetaxel].
September 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[Radiochemotherapy of inoperable esophageal cancer with 5-FU infusions].
January 1987, Zentralblatt fur Chirurgie,
Tomotaka Shibata, and Shinsuke Takeno, and Satoshi Watanabe, and Shoichi Fumoto, and Yoshiaki Takahashi, and Tsuyoshi Noguchi, and Katsunobu Kawahara
[Metastatic oropharyngeal cancer successfully treated with docetaxel, cisplatin, 5-FU and l-leucovorin].
January 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!